Literature DB >> 27649348

Compounded Topical Analgesics for Chronic Pain.

Abigail E Cline1, Jake E Turrentine.   

Abstract

Analgesic medications compounded for topical use are gaining popularity for the management of chronic pain. The advantages of topical pain medications include reduction of systemic adverse effects, improved patient acceptance, few drug interactions, ease of dose determination, avoidance of first-pass metabolism, and direct access to the target site. Compounded topical medications typically use a mixture of 3 or more single medications to achieve multiple complementary effects at lower doses of each individual medication. Herein, we review the mechanisms, adverse effects, and evidence for some of the most commonly used medications in topical compounds for pain management. Because more topical medications are used for chronic pain, dermatologists can expect an increase in irritant and allergic contact dermatitis related to these medications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27649348     DOI: 10.1097/DER.0000000000000216

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  5 in total

Review 1.  Chronic Scrotal Pain.

Authors:  Christopher Wu; Keith Jarvi
Journal:  Curr Urol Rep       Date:  2018-05-31       Impact factor: 3.092

Review 2.  Comprehensive Review of Topical Analgesics for Chronic Pain.

Authors:  Jillian Maloney; Scott Pew; Christopher Wie; Ruchir Gupta; John Freeman; Natalie Strand
Journal:  Curr Pain Headache Rep       Date:  2021-02-03

3.  Changes in pain and concurrent pain medication use following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational Optimizing Patient Experience and Response to Topical Analgesics study.

Authors:  Jeffrey A Gudin; Michael J Brennan; E Dennis Harris; Peter L Hurwitz; Derek T Dietze; James D Strader
Journal:  J Pain Res       Date:  2017-10-03       Impact factor: 3.133

4.  Improvement of Pain and Function After Use of a Topical Pain Relieving Patch: Results of the RELIEF Study.

Authors:  Jeffrey A Gudin; Derek T Dietze; Peter L Hurwitz
Journal:  J Pain Res       Date:  2020-06-26       Impact factor: 3.133

5.  Reducing Opioid Prescriptions by Identifying Responders on Topical Analgesic Treatment Using an Individualized Medicine and Predictive Analytics Approach.

Authors:  Jeffrey Gudin; Seferina Mavroudi; Aigli Korfiati; Konstantinos Theofilatos; Derek Dietze; Peter Hurwitz
Journal:  J Pain Res       Date:  2020-05-28       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.